Healthcare Industry News: GSK
News Release - February 25, 2019
Viriom Announces New CEO Appointment
SAN DIEGO, Feb. 25, 2019 -- (Healthcare Sales & Marketing Network) -- Viriom Inc. is pleased to announce the appointment of Iain Dukes, M.A., D.Phil., as its new CEO. Dr. Dukes brings to Viriom over 20 years of extensive experience in drug discovery, pharmaceutical research and business development, as well as in leadership and consulting for numerous biotech and venture capital organizations."Dr. Dukes' leadership expertise in development stage biotechs and in-depth expertise in pharmaceutical industry, as well as his knowledge of the most efficient partnering strategies will be a great contribution to Viriom's efforts in establishing a truly global commercial and development platform," said Nikolay Savchuk, PhD, Chairman of the Viriom Board.
"I am excited to join Nikolay and the Viriom team and look forward to assisting the company to fulfill its strategic objectives," commented Iain Dukes.
About Viriom
Viriom (San Diego, CA) focuses on the treatment, prophylaxis, and eradication of infectious diseases globally. Viriom is developing and commercializing the most innovative and affordable solutions to radically expand global access to the best antiviral treatments. Viriom's broad, proprietary, and partnered pipeline covers therapeutic, prophylactic, and curative medicines for HIV and viral hepatitis. Learn more at www.viriom.com.
Source: Viriom
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
